Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
The Co-IMPACT Consortium: Integrating prostate-specific membrane antigen positron emission tomography and radiotherapy in prostate cancer care.
Eur. Urol. 87, 379-384 (2025)
The Co-IMPACT consortium addresses knowledge gaps in prostate-specific membrane antigen positron emission tomography-guided radiotherapy for prostate cancer by establishing a global database (46 centres from 16 countries) to standardise and analyse data across four distinguished clinical scenarios. A collaborative model with the Advanced Prostate Cancer Consensus Conference aligns urgent clinical needs with actionable research insights.
Altmetric
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Editorial
Sprache
englisch
Veröffentlichungsjahr
2025
HGF-Berichtsjahr
2025
ISSN (print) / ISBN
0302-2838
e-ISSN
0302-2838
Zeitschrift
European Urology
Quellenangaben
Band: 87,
Heft: 4,
Seiten: 379-384
Verlag
Elsevier
Verlagsort
Radarweg 29, 1043 Nx Amsterdam, Netherlands
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Radiation Medicine (IRM)
POF Topic(s)
30203 - Molecular Targets and Therapies
Forschungsfeld(er)
Radiation Sciences
PSP-Element(e)
G-501300-001
Förderungen
Debiopharm
EU
Cypriot Research and Innovation Foundation (Agora3.0 project)
EU
Cypriot Research and Innovation Foundation (Agora3.0 project)
WOS ID
001454174500001
Scopus ID
85215369295
PubMed ID
39837736
Erfassungsdatum
2025-03-24